Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:1007-1011
Published online before print January 31, 2008, doi: 10.1161/STROKEAHA.107.496117
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/3/1007    most recent
STROKEAHA.107.496117v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saguchi, T.
Right arrow Articles by Furuhata, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saguchi, T.
Right arrow Articles by Furuhata, H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Animal models of human disease
Right arrow Other Stroke Treatment - Medical

(Stroke. 2008;39:1007.)
© 2008 American Heart Association, Inc.


Original Contributions

Effective and Safe Conditions of Low-Frequency Transcranial Ultrasonic Thrombolysis for Acute Ischemic Stroke

Neurologic and Histologic Evaluation in a Rat Middle Cerebral Artery Stroke Model

Takayuki Saguchi, MD; Hisashi Onoue, MD; Mitsuyoshi Urashima, MD; Toshihiro Ishibashi, MD; Toshiaki Abe, MD Hiroshi Furuhata, PhD, MD

From the Department of Neurosurgery (T.S., H.O., T.I., T.A.), the Medical Engineering Laboratory (H.F.), and the Division of Clinical Research and Development (M.U.), Jikei University School of Medicine, Tokyo, Japan.

Correspondence to Takayuki Saguchi, MD, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. E-mail takayukisaguchi{at}jikei.ac.jp

Background and Purpose— Transcranial ultrasound (TUS) enhances thrombolysis and is expected to be useful for the treatment of ischemic stroke. However, neither its effectiveness in improving neurologic outcome nor its safety in living tissue has been fully established. We examined the efficacy and safety of low-frequency TUS under appropriate conditions of ultrasound for thrombolytic treatment in a rat middle cerebral artery stroke model.

Methods— Sixty-five male Wistar rats were used. Rats with right middle cerebral artery stroke exhibiting left hemiparesis were blindly selected and randomly assigned to 1 of 3 groups: (1) control, no therapy; (2) tPA, intravenous administration of tissue plasminogen activator 3 hours after middle cerebral artery stroke, or (3) TUS, tPA administration and application of TUS (490 kHz, continuous wave, at an intensity of 0.8 W/cm2). Twenty-four hours after the onset of stroke, neurologic improvement was evaluated and brains were then removed. Thrombolysis at the origin of the right middle cerebral artery was examined. Thrombolysis ratio, cerebral infarct ratio, and rate of histologic evidence of hemorrhage were compared in the 3 groups.

Results— Significantly better neurologic improvement (P=0.008), a higher thrombolysis ratio (P=0.041), and a reduction of cerebral infarct volume (P=0.047) were obtained in the TUS group compared with the tPA group, without an increase in hemorrhagic transformation.

Conclusions— Our findings suggest that thrombolytic treatment with low-frequency TUS under appropriate conditions could be an effective and safe method of treatment for ischemic stroke.


Key Words: neurologic improvement • rats • safety • thrombolysis • ultrasound




This article has been cited by other articles:


Home page
Anticancer ResHome page
Y. MANOME, H. FURUHATA, A. HASHIMOTO, N. FUNAMIZU, R. SUZUKI, S. ISHIZAWA, N. AKIYAMA, T. KOBAYASHI, and M. WATANABE
Application of Therapeutic Insonation to Malignant Glioma Cells and Facilitation by Echo-contrast Microbubbles of Levovist
Anticancer Res, January 1, 2009; 29(1): 235 - 242.
[Abstract] [Full Text] [PDF]